常规杂质对照品,用于杂质谱定位、强制降解产物的峰归属以及外标法定量;建议同时确认主峰与相邻杂质峰的分离度 ≥1.5。A conventional impurity standard for impurity profiling, peak assignment of forced-degradation products and external-standard quantification; confirm resolution ≥1.5 between the main peak and adjacent impurities.
阿哌沙班ApixabanCAS 号No. 503612-47-3
Apixaban
| CAS 号CAS No. | 503612-47-3 |
| 分子式Molecular Formula | C25H25N5O4 |
| 分子量Molecular Weight | 459.51 g/mol |
| 分类Category | 药物标准品 / Pharmaceutical StandardsPharmaceutical Standards |
| 纯度Purity | >95% |
| 库存状态Stock | 现货In stock |
化学结构式Chemical structure

结构式由公开数据库渲染,仅供参考,以厂家图谱为准Structure rendered from public databases — indicative only
需要报价或 COA?Need a quote or COA?
直接联系销售顾问卢振明,附上本品 CAS 号即可(电话/微信/邮箱见页脚)。Contact our sales engineer Kaka Lu with this CAS number — phone, WeChat and e-mail are in the footer.
提交在线询价Submit enquiry产品介绍Product description
CATO 佳途供应阿哌沙班(Apixaban,CAS 号 503612-47-3),属于药物标准品。主要技术参数:分子式 C25H25N5O4;分子量 459.51 g/mol;纯度 >95%;供货状态 现货。产品随货提供纯度数据与结构确证资料,支持在线索取 COA 与分析证书。
Apixaban (CAS 503612-47-3) is supplied by CATO as pharmaceutical standards for analytical and quality-control use.
Molecular formula C25H25N5O4, molecular weight 459.51 g/mol. Supplied typically at >95% purity. Each lot is accompanied by purity data and, where applicable, structural confirmation data; a certificate of analysis (COA) is available on request.
Apixaban is intended for use as a calibration standard, system suitability reference or impurity marker in quantitative analysis by HPLC, GC, LC-MS/MS or GC-MS.
Full technical description and application notes are available in the Chinese datasheet. Please contact our sales engineer for a translated summary.
应用场景Application notes
—
Typical applications include: external-standard calibration curves; system suitability testing (resolution ≥ 1.5, peak-area RSD ≤ 2.0% over six injections); identification and quantification of related substances; forced-degradation and stability-indicating studies; and method validation for impurity limits. Prepare working solutions freshly for low-concentration use (<10 µg/mL) and protect from light.
Detailed recommended procedures are provided in the Chinese datasheet.
杂质信息与使用建议Impurity information and usage notes
以下为通行实践提示,供方法开发与采购决策参考。General practice notes to support method development and purchasing decisions.
标准品建议 −20 ℃ 避光、干燥、密封保存;配制成溶液后现配现用,并在记录中注明开瓶日期与所用溶剂。Store at −20 °C, protected from light and moisture, in a well-sealed container. Prepare solutions fresh and record the opening date and solvent used.
随货提供 COA 及 HPLC、MS、NMR 等多维度定值数据;可按批索取图谱原始文件。The COA is supplied with multi-dimensional value-assignment data (HPLC, MS, NMR); raw spectra are available per lot on request.
按名称归类为「标准品」。具体归属请以你们的工艺与降解研究结论为准。Classified by name as “Reference standard”. Final assignment should follow your own process and degradation studies.
询价 / 索取 COARequest a quote / COA
提交后由销售顾问 卢振明 直接对接,通常 1 个工作日内回复价格、纯度、规格与货期。Your enquiry goes directly to our sales engineer Kaka Lu, who normally replies with price, purity, pack size and lead time within one business day.
同品种其他杂质Other impurities of this drug substance
常见问题Frequently asked questions
阿哌沙班(CAS 503612-47-3)属于哪一类产品?What type of product is Apixaban (CAS 503612-47-3)?
阿哌沙班(CAS 503612-47-3)的分子式和分子量是多少?What are the molecular formula and molecular weight of Apixaban (CAS 503612-47-3)?
阿哌沙班(CAS 503612-47-3)的纯度和质量资料如何?What purity and documentation are provided for Apixaban (CAS 503612-47-3)?
阿哌沙班(CAS 503612-47-3)有哪些包装规格?What pack sizes are available for Apixaban (CAS 503612-47-3)?
阿哌沙班(CAS 503612-47-3)的结构与纯度如何确认?How are the structure and purity of Apixaban (CAS 503612-47-3) confirmed?
相关研究文献Related literature
以下为该品种在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.
- 杂质研究Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach
Biomedical chromatography : BMC · 2020 · Subramanian VB et al. · PMID 31634417 · DOI - 杂质研究Understanding the Stress Testing Characteristics of Apixaban, Structural Elucidation of a Novel Degradation Impurity, and Stability-Indicating Method Development for Quantification of Related Substances
Journal of AOAC International · 2024 · Surukonti SR, Surendrababu MS · PMID 37698982 · DOI - 杂质研究Establishing a multi-method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra-performance liquid chromatography (UPLC)
Biomedical chromatography : BMC · 2024 · Ganta S et al. · PMID 39394856 · DOI - 分析方法Analytical MethodsQuantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application
Therapeutic drug monitoring · 2018 · Lindahl S et al. · PMID 29578938 · DOI - 分析方法Analytical MethodsDevelopment, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma
Journal of pharmaceutical and biomedical analysis · 2020 · Gouveia F et al. · PMID 31981828 · DOI
相关资源Related resources
- 品种归属Drug substance:阿哌沙班阿哌沙班(查看该品种全部杂质条目view all impurity entries of this drug)
- 技术参考Technical reference:供应商目录编号与药典编号的区别Catalogue numbering vs. pharmacopoeial numbering
- 技术参考Technical reference:EP / USP / 中国药典杂质对照品体系差异EP / USP / ChP impurity reference standard systems